Cargando…
Proteomic analysis of plasma exosomes to differentiate malignant from benign pulmonary nodules
BACKGROUND: It is difficult to distinguish benign pulmonary nodules (PNs) from malignant PNs by conventional examination. Therefore, novel biomarkers that can identify the nature of PNs are needed. Exosomes have recently been identified as an attractive alternative approach since tumor-specific mole...
Autores principales: | Kuang, Muyu, Tao, Xiaoting, Peng, Yizhou, Zhang, Wenjing, Pan, Yafang, Cheng, Lei, Yuan, Chongze, Zhao, Yue, Mao, Hengyu, Zhuge, Lingdun, Zhou, Zhenhua, Chen, Haiquan, Sun, Yihua |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6359787/ https://www.ncbi.nlm.nih.gov/pubmed/30733650 http://dx.doi.org/10.1186/s12014-019-9225-5 |
Ejemplares similares
-
Integrated analysis of optical mapping and whole-genome sequencing reveals intratumoral genetic heterogeneity in metastatic lung squamous cell carcinoma
por: Peng, Yizhou, et al.
Publicado: (2020) -
Prognostic prediction of lung adenocarcinoma by integrative analysis of RHOH expression and methylation
por: Kuang, Muyu, et al.
Publicado: (2023) -
Super enhancer associated RAI14 is a new potential biomarker in lung adenocarcinoma
por: Yuan, Chongze, et al.
Publicado: (2017) -
Clinical Significance of Complex Glandular Patterns in Lung Adenocarcinoma: Clinicopathologic and Molecular Study in a Large Series of Cases
por: Kuang, Muyu, et al.
Publicado: (2018) -
Assessment of Plasma Proteomics Biomarker’s Ability to Distinguish Benign From Malignant Lung Nodules: Results of the PANOPTIC (Pulmonary Nodule Plasma Proteomic Classifier) Trial
por: Silvestri, Gerard A., et al.
Publicado: (2018)